We aim to strengthen our presence in emerging pharma hubs across Tier 2 and Tier 3 cities.
Express Pharma|December 2024
Dr Kiran Badgujar, Founder & Director, Aureole Pharmatech discusses his company's strategic initiatives to strengthen its presence in emerging pharma hubs, innovate through sustainable, customisable lab solutions, future technology investments and more, in an interview with Express Pharma
We aim to strengthen our presence in emerging pharma hubs across Tier 2 and Tier 3 cities.

How do you envision the role of Aureole Pharmatech evolving in response to advancements in the pharma and laboratory equipment industries?

At Aureole Pharmatech, we envision evolving by embracing smart technologies to improve equipment efficiency and precision, while also focusing on sustainability through energy-efficient, eco-friendly solutions. We aim to provide highly customisable, modular equipment that supports personalised medicine and specialised research needs. By staying ahead of regulatory changes, we ensure our equipment meets the highest standards for compliance and quality. Additionally, we are expanding our digital offerings with tools like remote monitoring and data analytics to optimise operational performance. Through strategic partnerships, we aim to drive innovation and address the industry's emerging challenges, keeping our clients at the forefront of pharma and laboratory advancements.

Could you share specific examples of recent innovations, and how these have influenced your product offerings?

This story is from the December 2024 edition of Express Pharma.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the December 2024 edition of Express Pharma.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM EXPRESS PHARMAView All
CILICANT is changing the way we think about active packaging
Express Pharma

CILICANT is changing the way we think about active packaging

Team CILICANT shared insights into their journey of innovation, customer-centric solutions, and their ambitious plans for global expansion. In this engaging dialogue, the team also shed light on their unique value proposition, recent achievements, and strategies for adapting to a rapidly evolving pharma landscape, in an exclusive conversation with Express Pharma

time-read
4 mins  |
January 2025
KPMG 2024 Life Sciences CEO Outlook
Express Pharma

KPMG 2024 Life Sciences CEO Outlook

This recent KPMG report explores the perspectives and priorities of life sciences CEOs amid economic and geopolitical uncertainty, focusing on growth strategies, digital transformation, ESG goals, and workforce challenges. Excerpts from the report

time-read
7 mins  |
January 2025
Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends
Express Pharma

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Industry experts highlight the evolving dynamics, regulatory needs, and personalised solutions driving the nutra market ahead of 2025

time-read
4 mins  |
January 2025
We aim to strengthen our presence in Asian and MENA regions, with particular emphasis on India
Express Pharma

We aim to strengthen our presence in Asian and MENA regions, with particular emphasis on India

Matthias Poslovski, Chief Sales Officer, Optima Pharma, speaks on the company's evolution and shares insights on emerging trends like personalised medicine, digitalisation, and Al-driven technologies, while outlining his company's strategies for market expansion, particularly in Asia and MENA, with a focus on the Indian pharma sector, in an exclusive interaction with Lakshmipriya Nair

time-read
4 mins  |
January 2025
Sustaining excellence: The evolving role of quality in pharma
Express Pharma

Sustaining excellence: The evolving role of quality in pharma

In the ever-evolving landscape of the pharma industry, the pursuit of quality remains a cornerstone of success. As stringent regulatory frameworks, rising patient expectations, and the increasing pace of innovation, transforms the pharma industry, the definition of quality is also evolving. From ensuring compliance with global standards to embracing cutting-edge technologies like Al-driven quality control, the industry is navigating a paradigm shift in how it approaches product integrity, safety, and efficacy. In this New Year issue, pharma experts explore how crucial it is to foster a culture of quality across organisations and deliver better healthcare outcomes

time-read
5 mins  |
January 2025
Revolutionising pharma the adaptive way
Express Pharma

Revolutionising pharma the adaptive way

Adaptive manufacturing offers better performance, efficient management of diverse products, a reduced machine footprint, faster batch changes, and enhanced operational sustainability

time-read
3 mins  |
January 2025
Trends 2025: Redefining the pharma supply chain
Express Pharma

Trends 2025: Redefining the pharma supply chain

Saurabh Gupta, Global Head of Supply Chain, Lupin highlights trends such as Al integration, digitalisation and sustainability that are shaping a future-ready supply chain

time-read
4 mins  |
January 2025
Growth mantras for 2025: Innovation, Partnerships, Sustainability
Express Pharma

Growth mantras for 2025: Innovation, Partnerships, Sustainability

Innovation, synergy, and sustainability are shaping the trajectory of India's pharma sector, unlocking new frontiers of growth, inform industry stakeholders

time-read
2 mins  |
January 2025
Will Epygen's biosimilars bets pay off?
Express Pharma

Will Epygen's biosimilars bets pay off?

Debayan Ghosh, founder, Epygen Group, has ambitious plans to snag a slice of the booming $70 billion global biosimilar pie. In a conversation with Viveka Roychowdhury, he analyses the journey so far, spanning pandemic preparedness projects like protein-based vaccines, building up pipeline revenue streams in diabetes, oncology, immunology and cardiovascular biosimilars, and his strategies to scale up and expand to other therapeutics like anti-obesity drugs

time-read
9 mins  |
January 2025
Innovation, partnerships and best practices: Priorities for biopharma in 2025
Express Pharma

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth

time-read
3 mins  |
January 2025